Detail of > 3230-94-2
- MSDS Download

- CAS Number:
- 3230-94-2
- Name:
L-Ornithine L-aspartate salt
- Formula:
- C5H12N2O2
- Molecular Structure:

- Synonyms:
- Orparan;(2S)-2-amino-4-hydroxy-4-oxobutanoate; [(4S)-4-amino-;L-Ornithine, L-aspartate (1:1);Ornithine, L-, L-aspartate (1:1) (8CI);Aspartic acid compd. with ornithine;Hepamerz;Ormeta;Ornithine aspartate;
- Molecular Weight:
- 265.26
- EINECS:
- 221-772-7
- Boiling Point:
- 308.7 °C at 760 mmHg
- Flash Point:
- 140.5 °C
- Appearance:
- white powder
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety:
- 26-37/39Details
- Deleted CAS:
- 91055-05-9|3054-39-5
Related products
- 3230-94-2L-Ornithine L-aspartate
- 67528-13-6Potassium Magnesium L-Aspartate
- 1913-12-84-tert-Butyl N-[(tert-butoxy)carbonyl]-L-aspartate dicyclohexylamine salt
- 185423-58-9L-Ornithine sulfate
- 72087-38-8L-Ornithine (3-methyl-2-oxobutyrate)
- 16748-29-1L-Ornithine, N2-methyl-
- 48047-95-6L-Ornithine, 2-methyl-
- 5144-42-3L-Ornithine 2-oxoglutarate
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 1945-78-4Benzothiazole,2,2'-methylenebis-
- 3230-94-2L-Ornithine L-aspartate
- 623-20-12-Propenoic acid,3-(2-furanyl)-, ethyl ester
- 5221-42-1Acetamide,N-4-pyridinyl-
- 25727-91-7Morpholine,4-hexadecyl-
- 23277-00-1Phosphonium,(1-naphthalenylmethyl)triphenyl-, chloride (1:1)
- 3115-66-0Phosphonium,tetrabutyl-, iodide (1:1)
- 5426-47-11H-Purine-2,6-dione,8-(dimethylamino)-3,9-dihydro-1,3-dimethyl-
- 54778-20-01H-Indole-3-carboxylicacid, 2-chloro-
- 70700-30-06-Aminopurine phosphate
- 5371-52-82-Furanol, tetrahydro-
- 4030-18-6Ethanone,1-(1-pyrrolidinyl)-
- 2905-68-2Benzoic acid,3,4-dichloro-, methyl ester
- 89007-45-4Benzene,1-isothiocyanato-4-(1-methylethyl)-
- 64262-23-3Piperazine, 1-propyl-,hydrobromide (1:2)
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(28)
India(2)
Germany(1)
- Business Type:
- Importer/Exporter(24)Lab/Research institutions(2)Other(1)
- Certificates:
- ISO(2) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- L-Ornithine vs
- L-Ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats. Vogels, B. A. P. M.; Karlsen, O. T.; Maas, M. A. W.; Bovee, W. M. M. J.; Chamuleau, R. A. F. M. (Academic Medical Center, Univ. Amsterdam, Amsterdam, Neth.). Journal of Hepatology, 26(1), 174-182 (English) 1997 Munksgaard. CODEN: JOHEEC. ISSN: 0168-8278. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) The effect of L-ornithine (ORN) and L-ornithine-L-aspartate (OA) therapy on "extracerebral" nitrogen metab., brain metab. and neurotransmission has been investigated in portacaval shunted rats with hyperammonemia-induced encephalopathy. One day before ammonium-acetate infusion, a portacaval shunt was performed in three exptl. groups: 1-control rats, 2-ORN-treated rats and 3 - OA-treated rats. Ammonium-acetate was given as an i.v. bolus injection (0.4 mmol×kg bw-1) followed by a const. infusion (1.9 mmol×kg bw-1×h-1) so that steady-state blood ammonia concns. (500-800 mM) were obtained in the course of 5 h. After 1 h, ammonium-acetate infusion, either L-ornithine or L-ornithine-L-aspartate, was infused for the next 4 h (3. 7664-41-7 and 3230-94-2 which are cas registry numbers of chemicals are mentioned.0 mmol×kg bw-1×h-1) in the treated groups. ORN and OA treatment resulted in significantly lower blood (34% and 39%) and brain (42% and 22%) ammonia concns., significantly higher urea prodn. (39% and 86%) and significantly smaller increases in brain glutamine and lactate concns. than in controls. These changes were assocd. with a significantly smaller increase in clin. grade of encephalopathy in ORN- and OA-treated rats, and a significant improvement in EEG activity in ORN-treated rats. OA-treated rats showed a significant increase in aspartate and glutamate concns. in brain dialyzate. The beneficial effects of both treatments on the manifestations of hyperammonemia-induced encephalopathy can be explained by a redn. in blood and brain ammonia concns. It is suggested that when OA is administered, the effect of ornithine is partly counteracted by aspartate, inducing high brain extracellular concns. of the two excitatory amino acids glutamate and aspartate, and perhaps causing overstimulation of NMDA receptors. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

